Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

(*) mandatory field


Other search option(s)

Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Synonym(s) NCAH
Prevalence >1 / 1000
Inheritance -
Age of onset Adolescent
  • E25.0
MeSH -
MedDRA -


Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (NCAH) is a common milder form of congenital adrenal hyperplasia (CAH; see this term) characterized by a later onset of androgen excess symptoms seen in females and precocious pseudopuberty in both sexes.

The prevalence ranges from 1/1,000-1/500 in the general Caucasian population, but up to 1-2% among inbred populations, such as Eastern European (Ashkenazi) Jews. It is not a rare disease.

Disease onset occurs in adolescence with variable degrees of postnatal androgen excess (precocious pubarche, hirsutism, acne, alopecia, anovulation and menstrual irregularies) and in the post-pubertal period it can mimic polycystic ovary syndrome (PCOS; see this term). It is also sometimes asymptomatic.

The disease is caused by a mutation in the CYP21A2 gene located on chromosome 6p21.3. In NCAH cortisol and aldosterone levels are normal but there is an increased amount of androgens.

The disease follows an autosomal recessive pattern of inheritance.

Expert reviewer(s)

  • Pr Juliane LEGER

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.

Captcha image

Detailed information

Summary information
Clinical practice guidelines
Article for general public
Clinical genetics review
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.